BEAM Beam Therapeutics Inc.
Nasdaq · SEC CIK 1745999 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $19.80M 22 sales by 7 insiders
- Filings on record
- 172 since 2021-07-02, latest 2026-07-29 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| FMR LLC | 10%, See Remark 1 | — | $10.05M |
| Evans John M. | CEO, Dir | — | $6.28M |
| Ciaramella Giuseppe | Pres | — | $1.41M |
| Bellon Christine | CLO | — | $881.0K |
| Simon Amy | Chief Medical Off | — | $606.7K |
| Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 161
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-29 16:05 | 2026-07-27 | BEAM | Simon Amy | Chief Medical Off | S - Sale | $25.74 | -16.7K | 85.7K | -16% | -$429.0K |
| T | 2026-07-02 16:05 | 2026-06-30 | BEAM | Simon Amy | Chief Medical Off | S - Sale | $34.73 | -373 | 102.4K | -0.4% | -$13.0K |
| DMT | 2026-07-01 16:05 | 2026-06-29+ | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.8956 | +50.0K | 1.07M | +5% | +$44.8K |
| DMT | 2026-07-01 16:05 | 2026-06-29+ | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $34.90 | -50.0K | 1.05M | -5% | -$1.75M |
| MI | 2026-06-29 14:17 | 2026-06-25+ | BEAM | FMR LLC | 10%, See Remark 1 | S - Sale | $35.24 | -284.9K | 854.6K | -25% | -$10.04M |
| DM | 2026-06-22 16:05 | 2026-06-17 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $0.964 | +35.5K | 253.9K | +16% | +$34.2K |
| T | 2026-04-06 17:48 | 2026-04-01 | BEAM | Evans John M. | CEO, Dir | S - Sale | $24.58 | -30.1K | 1.05M | -3% | -$739.3K |
| T | 2026-04-06 17:44 | 2026-04-01 | BEAM | Simon Amy | Chief Medical Off | S - Sale | $24.58 | -6,700 | 102.7K | -6% | -$164.7K |
| T | 2026-04-06 17:39 | 2026-04-01 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.58 | -3,242 | 51.2K | -6% | -$79.7K |
| T | 2026-04-06 17:39 | 2026-04-01 | BEAM | Bellon Christine | CLO | S - Sale | $24.58 | -5,956 | 109.7K | -5% | -$146.4K |
| T | 2026-04-06 17:34 | 2026-04-01 | BEAM | Ciaramella Giuseppe | Pres | S - Sale | $24.58 | -11.8K | 218.4K | -5% | -$290.3K |
| 2026-04-02 17:27 | 2026-03-31 | BEAM | Bellon Christine | CLO | A - Grant | $0.00 | +20.0K | 115.7K | +21% | $0 | |
| 2026-04-02 17:22 | 2026-03-31 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +20.0K | 54.8K | +57% | $0 | |
| 2026-04-02 17:16 | 2026-03-31 | BEAM | Simon Amy | Chief Medical Off | A - Grant | $0.00 | +31.8K | 109.1K | +41% | $0 | |
| 2026-04-02 17:16 | 2026-03-31 | BEAM | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +31.8K | 105.5K | +43% | $0 | |
| 2026-04-02 17:15 | 2026-03-31 | BEAM | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +40.0K | 230.2K | +21% | $0 | |
| DMT | 2026-04-01 18:32 | 2026-03-30+ | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| DMT | 2026-04-01 18:32 | 2026-03-30+ | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $22.57 | -50.0K | 986.7K | -5% | -$1.13M |
| DT | 2026-04-01 18:32 | 2026-03-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +90.0K | 1.08M | +9% | $0 |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $17.00 | +35.0K | 225.2K | +18% | +$595.0K |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Ciaramella Giuseppe | Pres | S - Sale+OE | $32.00 | -35.0K | 190.2K | -16% | -$1.12M |
| DMT | 2026-02-02 | 2026-01-29+ | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $28.87 | -50.0K | 986.7K | -5% | -$1.44M |
| DMT | 2026-02-02 | 2026-01-29+ | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| T | 2026-01-26 | 2026-01-22 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $35.00 | -6,198 | 34.8K | -15% | -$216.9K |
| T | 2026-01-26 | 2026-01-22 | BEAM | Bellon Christine | CLO | S - Sale | $34.00 | -1,371 | 95.7K | -1% | -$46.6K |
| T | 2026-01-21 | 2026-01-20 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $30.12 | -3,034 | 41.0K | -7% | -$91.4K |
| MT | 2026-01-20 | 2026-01-15 | BEAM | Bellon Christine | CLO | S - Sale | $34.62 | -18.6K | 97.0K | -16% | -$644.9K |
| T | 2026-01-05 | 2025-12-31 | BEAM | Emany Sravan Kumar | CFO | S - Sale | $27.10 | -6,294 | 73.7K | -8% | -$170.6K |
| 2026-01-05 | 2025-12-31 | BEAM | Simon Amy | Chief Medical Off | A - Grant | $0.00 | +12.5K | 77.4K | +19% | $0 | |
| T | 2026-01-05 | 2025-12-31 | BEAM | Bellon Christine | CLO | S - Sale | $27.10 | -1,254 | 115.7K | -1% | -$34.0K |
| I | 2025-10-29 | 2025-10-27 | BEAM | FMR LLC | 10%, See Remark 1 | S - Sale | $26.68 | -459 | 14 | -97% | -$12.2K |
| I | 2025-10-08 | 2025-10-06 | BEAM | FMR LLC | 10%, See Remark 1 | G - Gift | $0.00 | -1.23M | 841.2K | -59% | $0 |
| T | 2025-10-03 | 2025-10-01 | BEAM | Bellon Christine | CLO | S - Sale | $24.53 | -373 | 116.9K | -0.3% | -$9,150 |
| T | 2025-10-03 | 2025-10-01 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.53 | -467 | 44.0K | -1% | -$11.5K |
| DMT | 2025-10-03 | 2025-10-01+ | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $24.57 | -50.0K | 986.7K | -5% | -$1.23M |
| DMT | 2025-10-03 | 2025-10-01+ | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| I | 2025-08-01 | 2025-07-30 | BEAM | FMR LLC | 10%, See Remark 1 | S - Sale | $20.50 | -48.4K | 2.07M | -2% | -$991.7K |
| MT | 2025-07-03 | 2025-07-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $19.17 | -1,250 | 64.9K | -2% | -$24.0K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Ciaramella Giuseppe | Pres | S - Sale | $18.35 | -7,434 | 190.2K | -4% | -$136.4K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Evans John M. | CEO, Dir | S - Sale | $18.35 | -30.7K | 986.2K | -3% | -$562.7K |
| MT | 2025-04-03 | 2025-04-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $17.92 | -30.6K | 86.7K | -26% | -$547.8K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $18.35 | -3,015 | 44.5K | -6% | -$55.3K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Bellon Christine | CLO | S - Sale | $18.35 | -5,674 | 117.3K | -5% | -$104.1K |
| 2025-04-02 | 2025-03-31 | BEAM | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +35.0K | 197.7K | +22% | $0 | |
| 2025-04-02 | 2025-03-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +77.5K | 1.02M | +8% | $0 | |
| 2025-04-02 | 2025-03-31 | BEAM | Bellon Christine | CLO | A - Grant | $0.00 | +20.0K | 123.0K | +19% | $0 | |
| DAT | 2025-04-02 | 2025-01-30 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +30.0K | 968.7K | +3% | +$20.1K |
| 2025-04-02 | 2025-03-31 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +10.0K | 47.5K | +27% | $0 | |
| 2025-04-02 | 2025-03-31 | BEAM | Simon Amy | Chief Medical Off | A - Grant | $0.00 | +27.5K | 96.3K | +40% | $0 | |
| T | 2025-02-20 | 2025-02-18 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $35.00 | -6,287 | 37.5K | -14% | -$220.0K |
| DT | 2025-02-19 | 2025-02-14 | BEAM | Bellon Christine | CLO | S - Sale+OE | $34.00 | -10.0K | 103.0K | -9% | -$340.0K |
| DMT | 2025-02-19 | 2025-02-14 | BEAM | Bellon Christine | CLO | M - OptEx | $7.22 | +10.0K | 112.5K | +10% | +$72.2K |
| DMT | 2025-02-03 | 2025-01-30 | BEAM | Evans John M. | CEO, Dir | S - Sale | $26.75 | -30.0K | 908.9K | -3% | -$802.6K |
| T | 2025-01-06 | 2025-01-02 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.68 | -1,117 | 43.8K | -2% | -$27.6K |
| T | 2025-01-06 | 2025-01-02 | BEAM | Bellon Christine | CLO | S - Sale | $24.68 | -1,241 | 103.0K | -1% | -$30.6K |
| D | 2025-01-02 | 2024-12-31 | BEAM | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
| D | 2024-12-19 | 2024-12-17 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $0.67 | +53.5K | 162.7K | +49% | +$35.8K |
| T | 2024-11-08 | 2024-11-06 | BEAM | Ciaramella Giuseppe | Pres | S - Sale | $26.36 | -51.1K | 109.2K | -32% | -$1.35M |
| DMT | 2024-10-16 | 2024-10-14 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $2.00 | +41.8K | 209.9K | +25% | +$83.6K |
| DT | 2024-10-16 | 2024-10-14 | BEAM | Ciaramella Giuseppe | Pres | S - Sale+OE | $26.27 | -51.1K | 160.3K | -24% | -$1.34M |
| T | 2024-10-02 | 2024-10-01 | BEAM | Bellon Christine | CLO | S - Sale | $23.48 | -385 | 104.2K | -0.4% | -$9,040 |
| T | 2024-10-02 | 2024-09-30 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +2,500 | 45.2K | +6% | $0 |
| T | 2024-10-02 | 2024-10-01 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $23.48 | -289 | 44.9K | -0.6% | -$6,786 |
| T | 2024-10-02 | 2024-09-30 | BEAM | Evans John M. | CEO, Dir | S - Sale | $24.60 | -60.0K | 938.7K | -6% | -$1.48M |
| MT | 2024-07-03 | 2024-07-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $23.28 | -1,250 | 68.8K | -2% | -$29.1K |
| T | 2024-06-28 | 2024-06-27 | BEAM | Evans John M. | CEO, Dir | S - Sale | $24.50 | -60.0K | 998.3K | -6% | -$1.47M |
| D | 2024-04-29 | 2024-04-26 | BEAM | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +12.5K | 82.6K | +18% | $0 |
| DT | 2024-04-03 | 2024-04-01 | BEAM | Evans John M. | CEO, Dir | S - Sale | $32.13 | -18.1K | 1.06M | -2% | -$581.6K |
| MT | 2024-04-03 | 2024-04-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $31.02 | -23.7K | 86.6K | -21% | -$734.8K |
| DT | 2024-04-03 | 2024-04-01 | BEAM | Ciaramella Giuseppe | Pres | S - Sale | $32.12 | -4,534 | 169.6K | -3% | -$145.6K |
| T | 2024-04-03 | 2024-04-01 | BEAM | Burrell Terry-Ann | CFO | S - Sale | $32.12 | -5,446 | 70.1K | -7% | -$174.9K |
| T | 2024-04-03 | 2024-04-01 | BEAM | Bellon Christine | CLO | S - Sale | $32.12 | -3,401 | 104.6K | -3% | -$109.2K |
| 2024-04-02 | 2024-03-31 | BEAM | Simon Amy | Chief Medical Off | A - Grant | $0.00 | +27.5K | 93.7K | +42% | $0 | |
| 2024-04-02 | 2024-03-31 | BEAM | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +35.0K | 174.2K | +25% | $0 | |
| 2024-04-02 | 2024-03-31 | BEAM | Bellon Christine | CLO | A - Grant | $0.00 | +27.5K | 108.0K | +34% | $0 | |
| 2024-04-02 | 2024-03-31 | BEAM | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +27.5K | 75.6K | +57% | $0 | |
| T | 2024-04-01 | 2024-03-28 | BEAM | Evans John M. | CEO, Dir | S - Sale | $33.86 | -60.0K | 998.3K | -6% | -$2.03M |
| T | 2024-04-01 | 2024-03-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +77.5K | 1.08M | +8% | $0 |
| MI | 2024-02-15 | 2024-02-13+ | BEAM | FMR LLC | See Remark 1 | S - Sale | $30.55 | -901.6K | 2.77M | -25% | -$27.55M |
| DT | 2024-02-02 | 2024-01-31 | BEAM | Evans John M. | CEO, Dir | S - Sale | $25.33 | -60.0K | 1.06M | -5% | -$1.52M |
| T | 2024-01-05 | 2024-01-03 | BEAM | Bellon Christine | CLO | S - Sale | $26.42 | -1,907 | 80.5K | -2% | -$50.4K |
| I | 2023-12-27 | 2023-12-22 | BEAM | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -29.5K | 2.77M | -1% | $0 |
| DMT | 2023-11-22 | 2023-11-20 | BEAM | Bellon Christine | CLO | S - Sale+OE | $30.50 | -10.0K | 87.4K | -10% | -$305.0K |
| DMT | 2023-11-22 | 2023-11-20 | BEAM | Bellon Christine | CLO | M - OptEx | $7.22 | +10.0K | 86.6K | +13% | +$72.2K |
| T | 2023-11-01 | 2023-10-30 | BEAM | Simon Amy | Chief Medical Off | S - Sale | $18.70 | -3,448 | 65.5K | -5% | -$64.5K |
| D | 2023-10-24 | 2023-10-20 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +90.9K | 139.2K | +188% | +$60.9K |
| T | 2023-10-04 | 2023-10-02 | BEAM | Bellon Christine | CLO | S - Sale | $22.85 | -388 | 82.4K | -0.5% | -$8,866 |
| T | 2023-08-09 | 2023-07-10 | BEAM | Simon Amy | Chief Medical Off | S - Sale | $30.48 | -391 | 68.9K | -0.6% | -$11.9K |
| DMT | 2023-07-25 | 2023-07-21+ | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $7.22 | +92.5K | 49.5K | New | +$667.8K |
| DMT | 2023-07-25 | 2023-07-21+ | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $32.06 | -156.5K | 48.2K | -76% | -$5.02M |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale | $29.73 | -3,672 | 114.0K | -3% | -$109.2K |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Bellon Christine | CLO | S - Sale | $29.63 | -2,092 | 82.8K | -2% | -$62.0K |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $29.87 | -16.1K | 69.3K | -19% | -$480.9K |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Burrell Terry-Ann | CFO | S - Sale | $29.74 | -4,640 | 47.1K | -9% | -$138.0K |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Evans John M. | CEO, Dir | S - Sale | $29.63 | -11.7K | 1.12M | -1% | -$345.3K |
| D | 2023-03-31 | 2023-03-31 | BEAM | Ciaramella Giuseppe | Pres, CSO | A - Grant | $0.00 | +20.0K | 116.0K | +21% | $0 |
| 2023-03-31 | 2023-03-31 | BEAM | Simon Amy | Chief Medical Off | A - Grant | $0.00 | +20.0K | 85.1K | +31% | $0 | |
| D | 2023-03-31 | 2023-03-31 | BEAM | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +20.0K | 51.3K | +64% | $0 |
| D | 2023-03-31 | 2023-03-31 | BEAM | Evans John M. | CEO, Dir | A - Grant | $0.00 | +56.2K | 1.12M | +5% | $0 |
| D | 2023-03-31 | 2023-03-06 | BEAM | Evans John M. | CEO, Dir | L - Small Acq | $0.00 | +225 | 1.06M | +0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations